Le Lézard
Classified in: Health
Subject: SVY

Global Hemostasis Diagnostics Market 2018: Analysis of Major Current and Emerging Suppliers of Hemostasis Instruments and Reagents


DUBLIN, Dec. 18, 2018 /PRNewswire/ --

The "2018 Global Hemostasis Diagnostics Market Players - Market Shares by Country, Strategic Assessments of Major Suppliers and Emerging Market Entrants" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

This new report provides strategic assessments of major suppliers of hemostasis diagnostic products, as well as emerging market entrants.

The report presents analyses of major current and emerging suppliers of hemostasis instruments and reagents, including:

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/research/7rcc2k/global_hemostasis?w=5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

19 avr 2024
Remedium Healthcare Products is proud to announce the launch of NuVeria Labs' revolutionary Sacral Silicone Dressing, now available for purchase on Amazon, bringing advanced wound care solutions directly to consumers' doorsteps. Designed to address...

19 avr 2024
Getting specialty medications into...

19 avr 2024
Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious medals for product innovation at the 37th annual Edison Awards. "This product, along with our other innovations,...

19 avr 2024
Aligned with the trend of immersive water therapy in 2024, Baros Maldives' Serenity Spa stands out as an oasis of indulgent spa and beauty rituals, boasting a 50-year legacy of luxury. Nestled within a tranquil sanctuary amidst the lush Maldivian...

19 avr 2024
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...

19 avr 2024
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...



News published on and distributed by: